Fig. 2From: Adaptive designs in clinical trials: why use them, and how to run and report themOverview of the troxacitabine trial using a response-adaptive randomisation design. The probabilities shown are those at the time the patient on the x-axis was randomised. Coloured numbers indicate the arms to which the patients were randomisedBack to article page